Hypermobile Ehlers–Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing
Genes · 2025
DOI: 10.3390/genes16050530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Irman Forghani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Mount Sinai Medical Center of Florida, Miami Beach, FL 33140, USA. Hauptthemen laut MEDLINE: Ehlers-Danlos Syndrome, Genetic Testing, Joint Instability. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Hypermobile Ehlers–Danlos syndrome (hEDS) is the most common subtype of Ehlers–Danlos syndromes (EDS), a heterogeneous group of hereditary connective tissue disorders. The hallmark features of hEDS include generalized joint hypermobility (GJH), soft or velvety skin, and persistent joint pain. The molecular etiology of hEDS remains unknown, and diagnosis is primarily clinical. The updated diagnostic criteria for hEDS requires the fulfillment of three criteria: (1) GJH, (2) a combination of musculoskeletal and systemic manifestations consistent with a connective tissue disorder, and (3) the exclusion of alternative diagnoses. However, the exclusion process and the role of genetic testing have not yet been fully refined.
Methods
This retrospective review utilized data from the Hereditary Connective Tissue Disorders (HCTD) patient registry at the University of Miami, which includes individuals evaluated at the HCTD Clinic using a standardized internal clinical and genetic protocol. We analyzed data from 907 patients referred for hEDS evaluation between June 2019 and December 2022.
Results
Among these patients, 178 met the 2017 diagnostic criteria for hEDS. Genetic testing identified an alternative or additional diagnosis in 47 of these individuals (26.4%), with clinical implications requiring distinct management strategies.
Conclusions
These findings underscore the importance of criterion three—exclusion of alternative diagnoses—and highlight the critical yet underutilized role of genetic testing in the assessment of joint hypermobility. Furthermore, the results suggest that hypermobility may present a shared phenotype across a spectrum of disorders, including inflammatory diseases, monogenic syndromes, and chromosomal abnormalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Genetics, Mount Sinai Medical Center of Florida, Miami Beach, FL 33140, USA.
- Miller School of Medicine, University of Miami, Miami, FL 33146, USA.
ORCID-Profile: Irman Forghani, Julia See
Zitieren
APA
Forghani, I., See, J., & McGonigle, W. C. (2025). Hypermobile Ehlers–Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing. Genes. https://doi.org/10.3390/genes16050530
Vancouver
Forghani I, See J, McGonigle WC. Hypermobile Ehlers–Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing. Genes. 2025. doi:10.3390/genes16050530
BibTeX
@article{Forghani2025,
author = {Forghani, Irman and See, Julia and McGonigle, William C},
title = {Hypermobile Ehlers–Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16050530}
}
EUVIMED